Last reviewed · How we verify
SORBITOL
At a glance
| Generic name | SORBITOL |
|---|---|
| Drug class | Non-Standardized Food Allergenic Extract [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
- Diarrhea
- Vomiting
- Nausea
- Dehydration
- Electrolyte loss
- Dryness of mouth
- Thirst
- Marked diuresis
- Blurred vision
- Vertigo
- Chills
- Rhinitis
Serious adverse events
- Life-threatening reactions in fructose intolerance patients
- Fluid overload
- Acidosis
- Pulmonary congestion
- Hypotension
- Tachycardia
- Angina-like pains
- Convulsions
- Urinary retention
- Edema
Key clinical trials
- Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults (PHASE1)
- Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Microbiome Alterations With Xylitol (MAX) in Pregnancy (PHASE1, PHASE2)
- Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy (PHASE1, PHASE2)
- Comprehensive Multi-omics Characterization and Implications of Non-Pharmaceutical Dental Hygiene Product in a Randomized Controlled Large Population Study. (NA)
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults (PHASE1)
- Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial (PHASE2, PHASE3)
- Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SORBITOL CI brief — competitive landscape report
- SORBITOL updates RSS · CI watch RSS